Multiple signaling pathways such as the PI3K/AKT/mTOR, EGFR/RAS/MAPK, P53, and RB pathways have abnormal activity in GBM tumors (Ohgaki and Kleihues, 2007). This evidence concerns the gene EGFR and glioblastoma.